Design Pharmaceuticals
Latest round
- Series A
Last raised
- Jan 2022
Total raised
- $3M
Investors
- 1
About Design Pharmaceuticals
, doing business as, Design Pharma, is involved in small molecule drug research and development by utilizing biotechnologies to gain access to previously undiscovered molecules and speed up the drug discovery process. In January 2022, Design Pharmaceuticals, Inc. The company is a biotech firm that discovers small molecule drug compounds. The firm uses AI-guided biomining to screen compounds for G-protein coupled receptor (GPCR) screening from molecular sources such as chemical compound libraries, peptide and antibody libraries, DNA-encoded libraries, or patient samples, and build compounds to test various chemical structures built and biosynthetically create better compound candidates.
Who invested in Design Pharmaceuticals
1 investor across 1 round
See all investors in Design Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 12, 2022
Amount
$3M
Investors
Questions about Design Pharmaceuticals
Who invested in Design Pharmaceuticals?
Design Pharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Design Pharmaceuticals raised?
Design Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Design Pharmaceuticals last raise money?
Design Pharmaceuticals's most recent round on record is a Series A, in Jan 2022.
What does Design Pharmaceuticals do?
, doing business as, Design Pharma, is involved in small molecule drug research and development by utilizing biotechnologies to gain access to previously undiscovered molecules and speed up the drug discovery process.
Where is Design Pharmaceuticals headquartered?
Design Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Design Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Design Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Design Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.